Ilsung Pharmaceuticals Co., Ltd. (003120.KS)
003120.KS Stock Price Chart
Explore Ilsung Pharmaceuticals Co., Ltd. interactive price chart. Choose custom timeframes to analyze 003120.KS price movements and trends.
003120.KS Company Profile
Discover essential business fundamentals and corporate details for Ilsung Pharmaceuticals Co., Ltd. (003120.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
4 Jan 2000
Employees
224.00
Website
https://www.ilsung-ph.co.krCEO
Seok-geun Yoon
Description
Ilsung Pharmaceuticals Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, anti-coagulants, circulatory system drugs, contrast agents, diabetes treatments, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, anesthetics, antipyretics, and cardiovascular system products. Ilsung Pharmaceuticals Co., Ltd. was founded in 1954 and is headquartered in Seoul, South Korea.
003120.KS Financial Timeline
Browse a chronological timeline of Ilsung Pharmaceuticals Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 31 Dec 2024
EPS came in at ₩669.60 , while revenue for the quarter reached ₩16.87B .
Dividend declared on 27 Dec 2024
A dividend of ₩1.00K per share was announced, adjusted to ₩1.00K. The dividend was paid on 10 Apr 2025.
Earnings released on 30 Sept 2024
EPS came in at ₩1.41K , while revenue for the quarter reached ₩19.02B .
Earnings released on 29 Jun 2024
EPS came in at -₩61.89 , while revenue for the quarter reached ₩17.14B .
Earnings released on 30 Mar 2024
EPS came in at -₩97.81 , while revenue for the quarter reached ₩15.99B .
Earnings released on 30 Dec 2023
EPS came in at -₩5.83K , while revenue for the quarter reached ₩22.02B .
Dividend declared on 27 Dec 2023
A dividend of ₩1.50K per share was announced, adjusted to ₩1.50K. The dividend was paid on 11 Apr 2024.
Earnings released on 30 Sept 2023
EPS came in at ₩657.53 , while revenue for the quarter reached ₩18.07B .
Earnings released on 30 Jun 2023
EPS came in at -₩172.87 , while revenue for the quarter reached ₩20.03B .
Stock split effective on 17 Apr 2023
Shares were split 5 : 1 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Mar 2023
EPS came in at ₩2.12K , while revenue for the quarter reached ₩17.93B .
Earnings released on 31 Dec 2022
EPS came in at ₩205.31 , while revenue for the quarter reached ₩17.15B .
Dividend declared on 28 Dec 2022
A dividend of ₩20.00K per share was announced, adjusted to ₩4.00K. The dividend was paid on 11 Apr 2023.
Earnings released on 30 Sept 2022
EPS came in at ₩2.21K , while revenue for the quarter reached ₩15.99B .
Earnings released on 30 Jun 2022
EPS came in at ₩67.06K , while revenue for the quarter reached ₩13.04B .
Earnings released on 31 Mar 2022
EPS came in at ₩355.42 , while revenue for the quarter reached ₩15.07B .
Earnings released on 31 Dec 2021
EPS came in at ₩2.20K , while revenue for the quarter reached ₩12.57B .
Dividend declared on 29 Dec 2021
A dividend of ₩750.00 per share was announced, adjusted to ₩150.00. The dividend was paid on 13 Apr 2022.
Earnings released on 30 Sept 2021
EPS came in at ₩98.00 , while revenue for the quarter reached ₩10.61B .
Earnings released on 30 Jun 2021
EPS came in at ₩20.00 , while revenue for the quarter reached ₩10.12B .
Earnings released on 31 Mar 2021
EPS came in at -₩736.20 , while revenue for the quarter reached ₩8.79B .
Earnings released on 31 Dec 2020
EPS came in at ₩1.30K , while revenue for the quarter reached ₩10.22B .
Dividend declared on 29 Dec 2020
A dividend of ₩750.00 per share was announced, adjusted to ₩150.00. The dividend was paid on 7 Apr 2021.
Earnings released on 30 Sept 2020
EPS came in at ₩84.40 , while revenue for the quarter reached ₩9.77B .
003120.KS Stock Performance
Access detailed 003120.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.